Sentences with phrase «nih vaccine research»

He was requested by Dr. Vasee Moorthy, Head of the WHO Initiative for Vaccine Research, and recommended for the WHO assignment team by Dr. Barney Graham, Deputy Director of the NIH Vaccine Research Center (VRC), and Colonel Nelson Michael, Director of the MHRP.

Not exact matches

In the United States, the budget of the NIH's National Institute of Allergy and Infectious Diseases (NIAID) is about $ 4.5 billion for fiscal year 2008, and the WHO's Initiative for Vaccine Research budget was approximately $ 26.5 million for 2006 - 2007.

«Funding and commercial support are increasing in the area of vaccine R&D, especially because of the high investment by entities such as the NIH and the Bill & Melinda Gates Foundation,» noted Marie - Paule Kieny, director of the WHO's Initiative for Vaccine Revaccine R&D, especially because of the high investment by entities such as the NIH and the Bill & Melinda Gates Foundation,» noted Marie - Paule Kieny, director of the WHO's Initiative for Vaccine ReVaccine Research.

A team of scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases, part of NIH, created VRC07 - αCD3 under the leadership of VRC Director John R. Mascola, M.D.; former VRC Director Gary J. Nabel, M.D., Ph.D.; and Richard A. Koup, M.D., VRC deputy director and chief of its immunology laboratory.

By studying healthy people, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center, part of the NIH, and colleagues from King's College London have created a reference resource for other scientists.

Dr. Michael currently serves various NIH committees dealing with AIDS research and vaccines.

President Barack Obama gave a talk at the NIH Clinical Center and then toured the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center.

«Zika vaccines protect mice from infection: NIH - funded research suggests human vaccine is possible.»

The NIH's Vaccine Research Center (VRC) has developed a similar vaccine that is in earlier - stage tVaccine Research Center (VRC) has developed a similar vaccine that is in earlier - stage tvaccine that is in earlier - stage testing.

The NIH formed its own HIV vaccine trial network in 2000 to oversee clinical research sites in the U.S., Africa, Asia, the Caribbean and South America.

NIH scientists have discovered a mechanism involved in stabilizing key HIV proteins and thereby concealing sites where some of the most powerful HIV neutralizing antibodies bind, findings with potential implications for HIV vaccine research.

He also serves as a principal advisor to the director, NIAID / NIH, on vaccines and related biomedical research affairs.

Rama Rao Amara, a vaccine researcher at Emory Vaccine Center and Yerkes National Primate Research Center, and Harriet Robinson, former head of microbiology and immunology at Yerkes and now chief scientific officer at the firm GeoVax, both described extra ingredients for the DNA / MVA vaccine that Robinson designed while at Yerkes in collaboration with NIH reseavaccine researcher at Emory Vaccine Center and Yerkes National Primate Research Center, and Harriet Robinson, former head of microbiology and immunology at Yerkes and now chief scientific officer at the firm GeoVax, both described extra ingredients for the DNA / MVA vaccine that Robinson designed while at Yerkes in collaboration with NIH reseaVaccine Center and Yerkes National Primate Research Center, and Harriet Robinson, former head of microbiology and immunology at Yerkes and now chief scientific officer at the firm GeoVax, both described extra ingredients for the DNA / MVA vaccine that Robinson designed while at Yerkes in collaboration with NIH reseavaccine that Robinson designed while at Yerkes in collaboration with NIH researchers.

Funding: NIH's National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), and National Center for Research Resources (NCRR); the Bill and Melinda Gates Foundation; and the International AIDS Vaccine Initiative and its donors, including the U.S. Agency for International Development (USAID).

The vaccine, which was developed by the Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is a 6 - plasmid mixture encoding HIV envelope subtypes A, B, and C and subtype B gag, pol, and nef, and an rAd5 expressing identical genes, with the exception vaccine, which was developed by the Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is a 6 - plasmid mixture encoding HIV envelope subtypes A, B, and C and subtype B gag, pol, and nef, and an rAd5 expressing identical genes, with the exception Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is a 6 - plasmid mixture encoding HIV envelope subtypes A, B, and C and subtype B gag, pol, and nef, and an rAd5 expressing identical genes, with the exception of nef.

These studies were sponsored by the Vaccine Research Center (VRC), NIAID, NIH.

UNC School of Medicine's Aravinda de Silva, PhD, who is currently working on NIH - funded Zika vaccine development and other Zika research, is a co-author.

He is the recipient of several awards and honors, including the NIH Director's Translational Research Award and the Vaccine Industry Association Outstanding Academic Research Laboratory.

Researchers at NIH and the Walter Reed Army Institute of Research found that an investigational Ebola vaccine called VSV - ZEBOV was safe and produced robust antibody responses in healthy adults.